CELLGENTECH
CellGenTech is a Therapeutics Company. CellGenTech is currently exploring opportunities for alliances to advance the development of gene/cell therapy using Pre-Adipocytes Technology. We are now performing the translational clinical research for LCAT deficiency as the 1st target and trying to expand this new therapy to other rare diseases.
CELLGENTECH
Industry:
Biotechnology Therapeutics
Founded:
2003-10-20
Address:
Chiba, Chiba, Japan
Country:
Japan
Website Url:
http://www.cellgentech.com
Total Employee:
11+
Status:
Active
Contact:
043-441-4121
Email Addresses:
[email protected]
Total Funding:
3.61 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Euro Pound Sterling Japanese Yen
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Minutia
Biotech, Therapeutics
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Nissay Capital
Nissay Capital investment in Venture Round - CellGenTech
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital investment in Venture Round - CellGenTech
Nissui Pharmaceutical
Nissui Pharmaceutical investment in Corporate Round - CellGenTech
Official Site Inspections
http://www.cellgentech.com Semrush global rank: 2.05 M Semrush visits lastest month: 10.22 K
- Host name: www.gmoserver.jp
- IP address: 157.7.144.5
- Location: Tokyo Japan
- Latitude: 35.6882
- Longitude: 139.7532
- Timezone: Asia/Tokyo
- Postal: 102-0082
More informations about "CellGenTech"
General Information | CellGenTech, Inc.
Head Office. Chiba-dai Inohana Innovation Plaza #208, 1-8-15, Inohana, Chuo-ku, Chiba-city, Chiba 260-0856 Japan Map. Contact:[email protected]See details»
セルジェンテック株式会社
Aug 14, 2009 CellGenTech, Inc. 〒260-0856 千葉県千葉市中央区亥鼻1-8-15 千葉大亥鼻イノベーションプラザ101. 043-441-4121.See details»
CellGenTech, Inc.
CellGenTech Inc. signed a joint development and license agreement with Kyorin Pharmaceutical Co., Ltd. for GMAC of Fabry disease. June 17, 2022. Toho Holdings Co., Ltd. announced that …See details»
CellGenTech - Crunchbase Company Profile & Funding
CellGenTech is a Therapeutics Company. CellGenTech is currently exploring opportunities for alliances to advance the development of gene/cell therapy using Pre-Adipocytes Technology. …See details»
CellGenTech Company Profile 2024: Valuation, Funding
CellGenTech General Information Description. Developer of a bio-venture company designed to provide therapeutic products. The company is developing processed cellular therapy …See details»
Cellgentech Company Profile - Office Locations, Competitors
Cellgentech (셀젠텍) is a company that develops BIT convergence products for the pharmaceutical sector. Its products include FOBI, a device that can image and analyze …See details»
CellGenTech, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Aug 25, 2023 Explore CellGenTech, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, and 8 literature, Disease Domain:Hemic and Lymphatic ...See details»
CellGenTech - Company Profile - Tracxn
Dec 10, 2024 CellGenTech. has raised funding over 1 round. What are the most recent funding rounds of CellGenTech? Its latest funding round was a Seed round on Mar 19, 2019 for an …See details»
CellGenTech - Overview, News & Similar companies - ZoomInfo
CellGenTech contact info: Phone number: +81 434414121 Website: www.cellgentech.com What does CellGenTech do? CellGenTech is a bio-venture company in close coordination with …See details»
CellGenTech - Products, Competitors, Financials, Employees ...
CellGenTech is a biotechnology company focused on the development of gene therapies and regenerative medicine. The company specializes in the research and development of medical …See details»
CellGenTech - Funding, Financials, Valuation & Investors
CellGenTech is a Therapeutics Company. How much funding has this organization raised over time? ShowSee details»
再生医療ベンチャー#48 セルジェンテック | 再生医療.net
Oct 26, 2024 CellGenTech., Inc. 所在地 本社／ラボ：千葉県千葉市中央区亥鼻1-8-15 千葉大亥鼻イノベーションプラザ101 東京オフィス：東京都中央区日本橋堀留町1-9-10 日本橋ライフ …See details»
CELLGEN TECH,INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for !company_name! of !company_city_state!. Get the latest business insights from Dun & …See details»
CellGenTech - Contacts, Employees, Board Members, Advisors
CellGenTech has 4 current employee profiles, including Corporate Auditor Shiga Akira. CellGenTech has 3 board members and advisors, including Tanio Masami . ContactsSee details»
Mission & Vision | CellGenTech, Inc.
CellGenTech is a bio-venture company in close coordination with academia. We actively and intensely research and develop treatments by our Gene/ Cell therapy technologies and …See details»
セルジェンテック株式会社への追加出資について – ZACROS
当社は、成長領域である細胞培養受託事業の拡大を加速するため、バイオベンチャー「セルジェンテック株式会社」への投資契約を5月9日付で締結、5月10日付で3億円を追加出資いた …See details»
Our Platform | CellGenTech, Inc.
The Basic Concept of The GMAC Platform. The basic idea of the GMAC platform is to create a novel ex-vivo gene therapy in which subcutaneous fat is collected from patients, adipocytes …See details»
セルジェンテック株式会社｜スピーダ スタートアップ情報リサーチ
May 9, 2024 遺伝的な酵素・機能タンパク質欠損症の医薬品の開発。 家族性LCAT欠損症をはじめ、ライソゾーム病、血友病等の難治性疾患治療を目的とした遺伝子導入脂肪細胞医薬品の …See details»
Pipeline | CellGenTech, Inc.
CellGenTech is building a pipeline of innovative gene therapies through our GMAC platform to treat patients with genetic disorders such as LCAT deficiency, hemophilia A and B, Fabry …See details»
セルジェンテック株式会社への出資について – ZACROS
当社は、新たな成長領域である細胞培養受託事業の拡大を加速するため、10月13日付でバイオベンチャーである「セルジェンテック株式会社」の第三者割当増資を引き受け、1億円を出資 …See details»